プロバイオティクス栄養補助食品市場- 世界の産業規模、シェア、動向、機会、予測、形態別、最終用途別、用途別、地域別、競合別セグメント、2020-2030年

プロバイオティクス栄養補助食品の世界市場規模は2024年に87億6,000万米ドルとなり、2030年までの年間平均成長率（CAGR：Compound Annual Growth Rate）は10.75％と、予測期間中に力強い成長を遂げると予測されています。

消費者行動が科学的に検証された積極的な健康管理アプローチへと明確に移行していることを背景に、市場は急速な拡大を遂げています。プロバイオティクスは、腸と免疫の健康に役立つことが臨床的に証明された生きた微生物株であり、幅広い消費者層でエビデンスに基づく栄養戦略に不可欠な要素となっています。

このような採用の増加は、特に成人や高齢者の間で、胃腸障害、免疫反応の低下、慢性炎症など、生活習慣に関連した健康状態の有病率が増加していることと密接に結びついています。消費者は医薬品に頼らない自然な代替品に惹かれており、クリーンラベルの原則や予防的な健康習慣に沿ったプロバイオティクス製品に対する需要を煽っています。

主要市場促進要因

胃腸疾患および生活習慣関連疾患の有病率の上昇

主な市場課題

品質管理と製品の標準化

主要市場動向

個別化栄養の出現

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 形態別（チュアブル＆グミ、カプセル、粉末、錠剤＆ソフトジェル、その他）
  • 用途別（乳児、小児、成人、高齢者）
  • 用途別（スポーツフィットネス、エネルギーと体重管理、一般的な健康、骨と関節の健康、胃腸の健康、免疫、心臓の健康、糖尿病、抗がん、皮膚/髪/爪、脳/精神の健康、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ

第6章 北米のプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域のプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米のプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのプロバイオティクス栄養補助食品市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Probiotics Dietary Supplements Market was valued at USD 8.76 billion in 2024 and is projected to achieve strong growth over the forecast period, with a compound annual growth rate (CAGR) of 10.75% through 2030.

The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics-live microbial strains with clinically proven benefits for gut and immune health-are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.

This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation-particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.

Key Market Drivers

Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders

The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.

This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.

Key Market Challenges

Quality Control and Product Standardization

Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.

Key Market Trends

Emergence of Personalized Nutrition

The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition-including custom probiotic formulations-is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.

Key Market Players

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

Report Scope:

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Probiotics Dietary Supplements Market, By Form:

• Chewables & Gummies
• Capsules
• Powders
• Tablets & Softgels
• Others

Probiotics Dietary Supplements Market, By End-Use:

• Infants
• Children
• Adults
• Geriatric

Probiotics Dietary Supplements Market, By Application:

• Sports Fitness
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Skin/Hair/Nails
• Brain/Mental Health
• Others

Probiotics Dietary Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Probiotics Dietary Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 5.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map

6. North America Probiotics Dietary Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 6.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Probiotics Dietary Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By End-use
      • 6.3.1.2.3. By Applications
  • 6.3.2. Canada Probiotics Dietary Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By End-use
      • 6.3.2.2.3. By Applications
  • 6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By End-use
      • 6.3.3.2.3. By Applications

7. Europe Probiotics Dietary Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 7.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Probiotics Dietary Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By End-use
      • 7.3.1.2.3. By Applications
  • 7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By End-use
      • 7.3.2.2.3. By Applications
  • 7.3.3. France Probiotics Dietary Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By End-use
      • 7.3.3.2.3. By Applications
  • 7.3.4. Italy Probiotics Dietary Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By End-use
      • 7.3.4.2.3. By Applications
  • 7.3.5. Spain Probiotics Dietary Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By End-use
      • 7.3.5.2.3. By Applications

8. Asia-Pacific Probiotics Dietary Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 8.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Probiotics Dietary Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By End-use
      • 8.3.1.2.3. By Applications
  • 8.3.2. Japan Probiotics Dietary Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By End-use
      • 8.3.2.2.3. By Applications
  • 8.3.3. India Probiotics Dietary Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By End-use
      • 8.3.3.2.3. By Applications
  • 8.3.4. Australia Probiotics Dietary Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By End-use
      • 8.3.4.2.3. By Applications
  • 8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By End-use
      • 8.3.5.2.3. By Applications

9. South America Probiotics Dietary Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 9.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By End-use
      • 9.3.1.2.3. By Applications
  • 9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By End-use
      • 9.3.2.2.3. By Applications
  • 9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By End-use
      • 9.3.3.2.3. By Applications

10. Middle East and Africa Probiotics Dietary Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 10.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By End-use
      • 10.3.1.2.3. By Applications
  • 10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By End-use
      • 10.3.2.2.3. By Applications
  • 10.3.3. UAE Probiotics Dietary Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By End-use
      • 10.3.3.2.3. By Applications
  • 10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Form
      • 10.3.4.2.2. By End-use
      • 10.3.4.2.3. By Applications

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Vitakem Nutraceutical Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Lesaffre International Corp
• 14.3. DuPont de Nemours Inc
• 14.4. H&H Group PLC
• 14.5. Amway Corp
• 14.6. Abbott Laboratories Inc
• 14.7. Bayer AG
• 14.8. Pfizer Inc.
• 14.9. GSK PLC
• 14.10. BASF SE

15. Strategic Recommendations

16. About Us & Disclaimer